Mitch Morinec is a shareholder in the Chicago office of Segal McCambridge Singer & Mahoney and serves as chair of the firm's Life Sciences Practice Group. Mr. Morinec concentrates his practice in commercial, construction, intellectual property and products liability litigation as well as warranty consulting and litigation. He also represents nursing home and long-term care facilities in personal injury and wrongful death matters. Mr. Morinec has experience handling litigation matters in Illinois, Indiana, Wisconsin, Colorado, California, Arizona, New Mexico, Massachusetts and New York. Mr. Morinec also serves as a Cook County arbitrator.
Mr. Morinec was named to the Illinois “Forty Under 40" Illinois Attorneys to Watch by The Law Bulletin Publishing Company in 2017. Out of 1300 submissions for 2017, only 40 Illinois attorneys were chosen for this prestigious award.
In addition to his litigation practice, Mr. Morinec is a pro bono counsel for Lawyers for the Creative Arts, a non-profit organization that provides legal services to artists in the Chicagoland area, representing clients in intellectual property matters including copyright and trademark registration and protection, licensing negotiations, and general business disputes.
Mr. Morinec is an alumnus of Chicago’s legendary “City News Bureau,” where he covered and reported on crime in Chicago for numerous television, radio, and print media outlets locally and nationwide. He attended law school at DePaul University College of Law and is an alumnus of Washington University in St. Louis where he received an undergraduate degree in Economics and was a four-year letter winner for the University’s football team.
- Named to the 2017 Chicago Daily Law Bulletin's list of "Forty Under 40" Illinois Attorneys to Watch
- Recognized as an Illinois Leading Lawyer (a designation limited to less than 5% of all lawyers licensed to practice law in Illinois), nominated and selected by peers in the legal community, 2019-2021
- Named an Emerging Lawyer by Leading Lawyers (The distinction of being named an “Emerging Lawyer” is reserved for the top 2% of Illinois lawyers who are 40 years old or younger and have been identified by their peers as proving themselves to be professional, ethical and experienced at an early point in their legal career.) (2017-2018)Selected for inclusion in the Illinois Super Lawyers Rising Stars list (no more than 2.5% of lawyers in the state under the age of 40 are selected), nominated and selected by peers in the legal community, 2011-2019
- CALI Award - Excellence in Legal Writing
Professional & Civic Involvement
- Chicago Public Schools, Real Men Read program, volunteer
- Lawyers for the Creative Arts, pro bono counsel
- Successfully defended a client in a breach of contract trial in the Circuit Court of Dane County, Wisconsin. The plaintiff, a major real estate developer, sued its former employee for breach of contract alleging, among other things, that he committed fraud against the developer's company. After a bench trial, the judge ruled that no such fraud occurred, ruled in favor of Segal McCambridge's client, and awarded the plaintiff no damages. The contract at issue included an attorney's fees clause, which allows for the prevailing party at trial to recover its attorney's fees related to the litigation and trial.
- Achieved a trial verdict in the Circuit Court of Cook County, Illinois, in a lawsuit for injunctive relief on behalf of client who had signed a publishing agreement to convert her Ph.D. thesis into a mainstream book. The client sought representation after her publisher repeatedly neglected its duties under the publishing agreement and threatened to assert a percentage interest in any book deal the client would sign with another publishing house. In filing suit, Mr. Morinec sought an order declaring the contract null and void. At the conclusion of the trial, the Judge found in favor of the client and issued an Order declaring the publishing agreement null and void. The client is now free to pursue publishing her thesis with another publisher.
- After two years of litigation successfully obtained complete dismissal of lawsuit on behalf of condominium building management client in lawsuit claiming more than $1 million in damages by plaintiff alleging toxic mold exposure.
- Obtained dismissal outright on behalf of a multi-national prescription drug manufacturer in a products liability lawsuit alleging permanent neurological injury based on a recent United States Supreme Court ruling on the doctrine of federal pre-emption.
- Successfully defended appeal in the Illinois Appellate Court, First District, after prevailing on summary judgment on behalf of a privately held national company in a premises liability matter in the face of a $300,000 demand.
- Secured dismissal outright on behalf of Fortune 500 client in a commercial construction lawsuit claiming more than $12.5 million in total damages and $4.5 million against Segal McCambridge's client alone.
- Won summary judgment on behalf of a privately-held product manufacturer in a serious construction injury case where the plaintiff alleged strict liability.
- Obtained dismissal on summary judgment on behalf of multi-national client in six-figure construction-related claim resulting in dismissal of lawsuit in its entirety.
- Served as first-chair trial counsel on behalf of a Fortune 500 engineering firm in a commercial litigation trial where a $60+ million claim was being asserted solely at Mr. Morinec’s client. The case resolved after three weeks of trial.
Published Appellate Opinions
Healey v. I-Flow, LLC, 853 F. Supp. 2d 868 (D. Minn. 2012)
- Segal McCambridge Congratulates the 23 Attorneys Selected to the 2020 Leading and Emerging Lawyers Lists1.24.20
- Shareholder Mitch Morinec Named One of "Forty Under 40" Illinois Attorneys to Watch by the Chicago Daily Law Bulletin11.17.17
- Segal McCambridge Attorneys Jeff Singer, Kim Kayiwa, and Mitch Morinec Gain Dismissal on Behalf of Generic Drug Manufacturer in High Damages Products Liability Case2.17.12
- Segal McCambridge in Chicago Kicks Off CBF's Investing in Justice Campaign and Aims for 90% Participation in Pro Bono3.5.10
Panelist: DePaul University College of Law, Chicago, IL, "Remedies in the Real World of Litigation" (April 2011, November 2011, November 2012, November 2013, November 2014).
Speaker: Chicago Bar Association Section of Commercial Litigation, "Challenging a Trial Court Discovery Order via Civil Contempt" (November 2012).
Panel Judge: Loyola University School of Law, "Federal Appellate Advocacy" (November 2009).
Panelist: DePaul University College of Law, Chicago, IL, "Legal Writing in the Real World" (October 1, 2008).
"Civil Contempt as a Means of Challenging a Trial Court Discovery Order: What Attorneys Should Know for Purposes of Obtaining Appellate Jurisdiction," CBA Record, Vol. 25, No. 6, September 2011. (To read, click here.)
"LexisNexis Practice Guide: Illinois Personal Injury Litigation" (2019 Edition).
"LexisNexis Practice Guide: Illinois Personal Injury Litigation" (2018 Edition).
"LexisNexis Practice Guide: Illinois Personal Injury Litigation" (2017 Edition).
“LexisNexis Practice Guide: Illinois Personal Injury Litigation” (2020 Edition)
"LexisNexis Practice Guide: Illinois Personal Injury Litigation" (2015 Edition).
"LexisNexis Practice Guide: Illinois Personal Injury Litigation" (2014 Edition).
- Placebo Effect: How Illinois’ COVID Tort Immunity Fails to Immunize Medical Professionals and the Healthcare Industry4.19.21
- If at First You Do Not Succeed, Try Again Immediately: Illinois Passes Revised Pre-Judgment Interest Statute3.30.21
- Prejudgment Interest Starting as Early as the Time of Injury? At a Rate of 9% Interest? A Bill Sits on Illinois’ Governor’s Desk.1.21.21
- Illinois Appellate Court Says the Learned Intermediary Doctrine Does Not Shield a Device Manufacturer from Liability When a Doctor is Deceived About a Device’s Prior Testing and Suitability11.9.20
- What is Amy Coney Barrett’s Record on Federal Preemption and What Does it Mean for Future SCOTUS Rulings in Drug and Medical Device Litigation?10.27.20
- LIFE SCIENCES CLIENT ALERT: United States Supreme Court holds that the judge, not the jury, makes pre-emption determination in failure-to-warn pharmaceutical cases.5.22.19
DePaul University College of Law, J.D., 2006
Washington University in St. Louis, B.A., 2002
- Illinois, 2006
- Wisconsin, 2019
- Federal Trial Bar, 2007
- U.S. District Court for the Northern District of Illinois, 2006
- U.S. District Court for the Eastern District of Wisconsin, 2007
- U.S. Court of Appeals for the Seventh Circuit, 2010